{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T18:15:14Z","timestamp":1778782514366,"version":"3.51.4"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":118,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018488","name":"University of Florida Clinical and Translational Science Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018488","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institutes of Health National Center for Advancing Translational Sciences","award":["UL1TR001427"],"award-info":[{"award-number":["UL1TR001427"]}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Glioblastoma (GBM) continues to have poor prognosis with minimal improvement since the introduction of the Stupp protocol. While clinical data are often homogenous and not generalizable, real-world data can be used to identify more specific risk factors for poor outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Utilizing our proprietary computerized phenotype, we identified adult GBM patients at the University of Florida (UF) and the OneFlorida+ CRN database from 2011 to 2021. The chi-square test was used to compare demographic variables between the 2 groups. Additionally, the effect of medical comorbidities and the Charlson Comorbidity Index on overall survival was evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 380 and 1630 GBM patients were identified from UF and OneFlorida+, respectively. UF patients were older, with a lower percentage of minority races. Patients with seizures, hypertension, and dementia had the longest median survival, while those with liver disease and diabetes had the lowest median survival. Older age at diagnosis, presenting with paraplegia or hemiplegia, diabetes, liver disease, and hyperlipidemia were all found to be significant predictors of mortality on multivariate Cox analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>An estimated 20% of GBM patients participate in clinical trials, limiting the generalizability of results. It is imperative to continue to work towards obtaining high-volume real-world data to improve our understanding of this devastating condition. Here, we confirm that GBM cohorts can be identified in large databases and, using this real-world data, identified several comorbidities that confer worse or better survival times for patients with GBM. This data can be used to improve patient stratification and counseling.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/noajnl\/vdag098","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T11:34:29Z","timestamp":1777116869000},"source":"Crossref","is-referenced-by-count":0,"title":["Real-world mortality and the effect of comorbidities on survival in glioblastoma: A database study using computed phenotypes for rapid, reliable patient identification"],"prefix":"10.1093","volume":"8","author":[{"given":"Ruoqi","family":"Wei","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, College of Medicine, University of Florida , Gainesville, Florida,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7665-2692","authenticated-orcid":false,"given":"Megan E H","family":"Still","sequence":"additional","affiliation":[{"name":"Department of Health Outcomes & Biomedical Informatics, College of Medicine, University of Florida , Gainesville, Florida,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel S F","family":"Moor","sequence":"additional","affiliation":[{"name":"Department of Health Outcomes & Biomedical Informatics, College of Medicine, University of Florida , Gainesville, Florida,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, College of Medicine, University of Florida , Gainesville, Florida,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianchen","family":"Lyu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, College of Medicine, University of Florida , Gainesville, Florida,","place":["USA"]},{"name":"Cancer Informatics Shared Resource, University of Florida Health Cancer Center , Gainesville, Florida,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Health Outcomes & Biomedical Informatics, College of Medicine, University of Florida , Gainesville, Florida,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0290-8058","authenticated-orcid":false,"given":"Xing","family":"He","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, College of Medicine, University of Florida , Gainesville, Florida,","place":["USA"]},{"name":"Cancer Informatics Shared Resource, University of Florida Health Cancer Center , Gainesville, Florida,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duane A","family":"Mitchell","sequence":"additional","affiliation":[{"name":"Department of Health Outcomes & Biomedical Informatics, College of Medicine, University of Florida , Gainesville, Florida,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Shenkman","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, College of Medicine, University of Florida , Gainesville, Florida,","place":["USA"]},{"name":"Cancer Informatics Shared Resource, University of Florida Health Cancer Center , Gainesville, Florida,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, College of Medicine, University of Florida , Gainesville, Florida,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0587-4105","authenticated-orcid":false,"given":"Yi","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, College of Medicine, University of Florida , Gainesville, Florida,","place":["USA"]},{"name":"Cancer Informatics Shared Resource, University of Florida Health Cancer Center , Gainesville, Florida,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiang","family":"Bian","sequence":"additional","affiliation":[{"name":"Walther and Regenstrief Institute, Biostatistics & Health Data Science, Indiana University , Bloomington, Indiana,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley Parham","family":"Ghiaseddin","sequence":"additional","affiliation":[{"name":"Department of Health Outcomes & Biomedical Informatics, College of Medicine, University of Florida , Gainesville, Florida,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"2026051413335599900_vdag098-B1","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med"},{"key":"2026051413335599900_vdag098-B2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/14760584.2016.1218762","article-title":"Advances and challenges: dendritic cell vaccination strategies for glioblastoma","volume":"16","author":"Schaller","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"2026051413335599900_vdag098-B3","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noad149","article-title":"CBTRUS statistical report: primary brain and other Central nervous system tumors diagnosed in the United States in 2016-2020","volume":"25","author":"Ostrom","year":"2023","journal-title":"Neuro-Oncol"},{"key":"2026051413335599900_vdag098-B4","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1093\/neuonc\/noac125","article-title":"Risk of intracranial hemorrhage with direct oral anticoagulants vs low molecular weight heparin in glioblastoma: a retrospective cohort study","volume":"24","author":"Reed-Guy","year":"2022","journal-title":"Neuro-Oncol"},{"key":"2026051413335599900_vdag098-B5","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1093\/neuonc\/noad249","article-title":"Developing a computable phenotype for glioblastoma","volume":"26","author":"Yan","year":"2024","journal-title":"Neuro-Oncol"},{"key":"2026051413335599900_vdag098-B6","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"2026051413335599900_vdag098-B7","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"2026051413335599900_vdag098-B8","doi-asserted-by":"publisher","first-page":"vdab008","DOI":"10.1093\/noajnl\/vdab008","article-title":"Real-world validity of randomized controlled phase III trials in newly diagnosed glioblastoma: to whom do the results of the trials apply?","volume":"3","author":"Skaga","year":"2021","journal-title":"Neurooncol Adv"},{"key":"2026051413335599900_vdag098-B9","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1158\/1078-0432.CCR-21-2750","article-title":"Glioblastoma clinical trials: current landscape and opportunities for improvement","volume":"28","author":"Bagley","year":"2022","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"2026051413335599900_vdag098-B10","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1093\/neuonc\/noz104","article-title":"Barriers to accrual and enrollment in brain tumor trials","volume":"21","author":"Lee","year":"2019","journal-title":"Neuro-Oncol"},{"key":"2026051413335599900_vdag098-B11","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.22034\/APJCP.2018.19.9.2613","article-title":"Survival analysis of glioblastoma multiforme","volume":"19","author":"Witthayanuwat","year":"2018","journal-title":"Asian Pac J Cancer Prev APJCP"},{"key":"2026051413335599900_vdag098-B12","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1093\/neuonc\/noac198","article-title":"National-level overall survival patterns for molecularly-defined diffuse glioma types in the United States","volume":"25","author":"Ostrom","year":"2023","journal-title":"Neuro-Oncol"},{"key":"2026051413335599900_vdag098-B13","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1108\/JHTI-07-2023-0485","article-title":"Should I stay or should I go back? Factors influencing snowbirds\u2019 permanent relocation intention","volume":"7","author":"Chaulagain","year":"2024","journal-title":"J Hosp Tour Insights"},{"key":"2026051413335599900_vdag098-B14","doi-asserted-by":"publisher","first-page":"3478","DOI":"10.1007\/s12032-012-0263-3","article-title":"Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective Mono-institutional phase II studies","volume":"29","author":"Balducci","year":"2012","journal-title":"Med Oncol Northwood Lond Engl"},{"key":"2026051413335599900_vdag098-B15","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12883-021-02532-x","article-title":"Age-adjusted charlson comorbidity index in recurrent glioblastoma: a new prognostic factor?","volume":"22","author":"Barz","year":"2022","journal-title":"BMC Neurol"},{"key":"2026051413335599900_vdag098-B16","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1007\/s00432-014-1907-9","article-title":"Charlson comorbidity index: an additional prognostic parameter for preoperative glioblastoma patient stratification","volume":"141","author":"Ening","year":"2015","journal-title":"J Cancer Res Clin Oncol"},{"key":"2026051413335599900_vdag098-B17","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.1007\/s12032-012-0246-4","article-title":"Comorbidity assessment and adjuvant radiochemotherapy in elderly affected by glioblastoma","volume":"29","author":"Fiorentino","year":"2012","journal-title":"Med Oncol Northwood Lond Engl"},{"key":"2026051413335599900_vdag098-B18","doi-asserted-by":"publisher","first-page":"20018","DOI":"10.1038\/s41598-019-56574-w","article-title":"Comorbid medical conditions as predictors of overall survival in glioblastoma patients","volume":"9","author":"Carr","year":"2019","journal-title":"Sci Rep"},{"key":"2026051413335599900_vdag098-B19","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1634\/theoncologist.2018-0056","article-title":"The association between common clinical characteristics and postoperative morbidity and overall survival in patients with glioblastoma","volume":"24","author":"Liu","year":"2019","journal-title":"Oncologist"},{"key":"2026051413335599900_vdag098-B20","doi-asserted-by":"publisher","first-page":"vdab083","DOI":"10.1093\/noajnl\/vdab083","article-title":"Predictors of survival in elderly patients undergoing surgery for glioblastoma","volume":"3","author":"Voisin","year":"2021","journal-title":"Neurooncol Adv"},{"key":"2026051413335599900_vdag098-B21","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/hr.2015.66","article-title":"Chronic arterial hypertension impedes glioma growth: a multiparametric MRI study in the rat","volume":"38","author":"Letourneur","year":"2015","journal-title":"Hypertens Res Off J Jpn Soc Hypertens"},{"key":"2026051413335599900_vdag098-B22","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.7150\/jca.63609","article-title":"Cholesterol metabolism and its implication in glioblastoma therapy","volume":"13","author":"Guo","year":"2022","journal-title":"J Cancer"},{"key":"2026051413335599900_vdag098-B23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3171\/2016.7.JNS16396","article-title":"The effects of new or worsened postoperative neurological deficits on survival of patients with glioblastoma","volume":"127","author":"Rahman","year":"2017","journal-title":"J Neurosurg"},{"key":"2026051413335599900_vdag098-B24","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1200\/JCO.2008.19.1098","article-title":"Association between hyperglycemia and survival in patients with newly diagnosed glioblastoma","volume":"27","author":"Derr","year":"2009","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"2026051413335599900_vdag098-B25","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1093\/neuonc\/nos056","article-title":"Severe sustained cholestatic hepatitis following temozolomide in a patient with glioblastoma multiforme: case study and review of data from the FDA adverse event reporting system","volume":"14","author":"Sarganas","year":"2012","journal-title":"Neuro-Oncol"}],"container-title":["Neuro-Oncology Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/noa\/advance-article-pdf\/doi\/10.1093\/noajnl\/vdag098\/68189372\/vdag098.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/noa\/article-pdf\/8\/1\/vdag098\/68189372\/vdag098.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/noa\/article-pdf\/8\/1\/vdag098\/68189372\/vdag098.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T17:34:05Z","timestamp":1778780045000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/noa\/article\/doi\/10.1093\/noajnl\/vdag098\/8665121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,12]]}},"URL":"https:\/\/doi.org\/10.1093\/noajnl\/vdag098","relation":{},"ISSN":["2632-2498"],"issn-type":[{"value":"2632-2498","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2026,1]]},"article-number":"vdag098"}}